Vaccines - Sudan

Sudan

The Vaccines market in Sudan is expected to achieve a revenue of US$105.20m in 2024.
Looking ahead, it is forecasted to witness a compound annual growth rate (CAGR 2024-2029) of -18.30%, leading to a market volume of US$38.30m by 2029.
When comparing globally, United States is projected to generate the highest revenue of US$29,120.00m in 2024.
Sudan, with its high prevalence of infectious diseases, has seen an increased demand for vaccines to combat the spread of diseases such as malaria and yellow fever.

Key regions: Australia, Italy, France, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

Sudan, a country located in Northeast Africa, has been facing several challenges in the healthcare sector, including the availability and accessibility of vaccines. Despite these challenges, the vaccines market in Sudan has been developing in recent years.

Customer preferences: Sudan has a high demand for vaccines due to the prevalence of infectious diseases such as measles, polio, and meningitis. The government and international organizations such as UNICEF have been working to increase vaccination coverage in the country. However, there is still a lack of awareness among some segments of the population, particularly in rural areas, about the importance of vaccines.

Trends in the market: The vaccines market in Sudan has been growing due to various factors. Firstly, the government has been increasing its investment in the healthcare sector, including the procurement of vaccines. Secondly, international organizations such as UNICEF have been providing support to the government in terms of funding and technical assistance. Thirdly, there has been an increase in the number of private healthcare providers in the country, which has contributed to the availability of vaccines.

Local special circumstances: Sudan has been facing several challenges in the healthcare sector, including a shortage of healthcare workers, inadequate healthcare infrastructure, and political instability. These challenges have affected the availability and accessibility of vaccines in the country. In addition, the country has been facing economic challenges, including high inflation and a shortage of foreign currency, which has affected the procurement of vaccines.

Underlying macroeconomic factors: The vaccines market in Sudan is influenced by various macroeconomic factors. Firstly, the country's economy has been affected by the COVID-19 pandemic, which has led to a decline in economic activity and a reduction in government revenue. Secondly, the country has been facing high inflation, which has affected the affordability of vaccines for some segments of the population. Thirdly, the country has been facing a shortage of foreign currency, which has affected the procurement of vaccines and other healthcare supplies.In conclusion, the vaccines market in Sudan has been developing in recent years, driven by government investment, international support, and an increase in the number of private healthcare providers. However, the market still faces challenges related to healthcare infrastructure, political instability, and economic challenges. The government and international organizations need to continue their efforts to increase vaccination coverage in the country and address the underlying macroeconomic challenges affecting the vaccines market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.